CureVac Hope to Start Rollout of Their Vaccine in June – Company CEO
Coronavirus vaccine maker CureVac has said it hopes its Covid shot will receive European approval in the second quarter.
CureVac’s CEO Franz-Werner Haas told CNBC Thursday that the vaccine maker was close to finalizing the recruitment for the vaccine’s Phase 3 clinical trial. Approval could come not long after, he said, given the urgent need for additional effective coronavirus vaccines and the expedited regulatory approval process.
“We are expecting, according to our calculations, that towards the end of April or beginning of May that we will have the data,” Haas told CNBC’s Squawk Box Europe.
“So we expect to be given approval, depending on the data certainly, in the beginning of June.”
Once the trial is underway, the German biotech CureVac will wait for safety data and then conduct an interim analysis of results from the late-stage study. Crucially, it will also have to wait until a certain number of trial participants develop Covid-19 in order to see how effective the vaccine is at preventing the virus.
The data is then submitted to regulatory authorities, such as the European Medicines Agency, for what’s called a “rolling review;” this is where the data is analyzed by regulators as it emerges, speeding up the assessment of new, potentially life-saving vaccines or medicines during public health emergencies.
The U.K. and EU have pre-ordered up to 455 million doses of CureVac’s mRNA vaccine, subject to regulatory approval. The company is already producing its vaccine, despite the fact it has not yet been authorized, in anticipation of the shot’s approval.
We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!
- » Germany to Step on “Emergency Break” to Curb Third Wave of Coronavirus Infections
- » Shots from Different Vaccines Should Not Be Mixed Says WHO Representative in Bulgaria
- » Covid-19 Death Toll in Europe Surpassed One Million
- » WHO: Coronavirus Pandemic Is Far from Being Over
- » Bulgaria: Experts to Decide What to Do with AstraZeneca Vaccine
- » Covid-19 in Bulgaria: 3,122 Newly Infected, 201 Fatalities